Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 817–840 of 998 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Comparison control condition Clear all

Conditions: Mild Traumatic Brain Injury (mTBI), Traumatic Brain Injury, Anger
Interventions: Man Therapy; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older · Male only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Colorado Springs, Colorado

Conditions: Spinal Cord Injuries
Interventions: Low-frequency Exercise, High-frequency Exercise; Other
Lead sponsor: Richard K Shields; Other
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Iron Deficiency Anemia
Interventions: Ferumoxytol, Oral Iron; Drug
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Bladder Cancer, Bladder Stone, Bladder Outlet Obstruction, Renal Stone, Renal Disease
Interventions: Cystoscopy with RedPine flexible disposable cystoscope, Cystoscopy with standard of care flexible reusable scope; Device
Lead sponsor: Guangzhou Red Pine Medical Instrument Co., Ltd.; Industry
Eligibility: 18 Years to 120 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Hersey, Pennsylvania • Dallas, Texas • Seattle, Washington

Conditions: Amblyopia, Binocular Vision Disorder
Interventions: Binocular cartoon treatment at home, Patching, Binocular cartoon treatment in office; Other
Lead sponsor: University of Waterloo; Other
Eligibility: 36 Months to 83 Months
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Covid19
Interventions: Acebilustat, Camostat; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Pleasanton, California • Stanford, California

Conditions: Rheumatoid Arthritis
Interventions: INCB028050, Placebo; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 41
States / cities: Birmingham, Alabama • Paradise Valley, Arizona • Peoria, Arizona + 38 more

Conditions: Headache Disorders
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Pectus Excavatum
Interventions: Hydromorphone, Morphine; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 8 Years to 18 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Nonsuicidal Self-injury, Depression, Anxiety
Interventions: App-based digital mental health intervention for adolescent NSSI, App-based delivery of healthy living psychoeducational materials; Device
Lead sponsor: Northwestern University; Other
Eligibility: 14 Years to 18 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression, Unipolar, Fall
Interventions: Behavioral Activation, Fall Prevention, Telephone support; Behavioral · Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 50 Years to 100 Years
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Unspecified Child Maltreatment, Suspected, Unspecified Child Maltreatment, Confirmed
Interventions: Durham Connects; Other
Lead sponsor: Duke University; Other
Eligibility: Up to 6 Months
Enrollment: 1,650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature, Small for Gestational Age at Delivery
Interventions: Lonapegsomatropin [SKYTROFA®], Somatropin Pen Injector; Combination Product
Lead sponsor: Ascendis Pharma A/S; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 27
States / cities: Phoenix, Arizona • Palo Alto, California • Sacramento, California + 23 more

Conditions: Stroke, Dysphagia
Interventions: Mendelsohn Maneuver; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 21 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Autism, Cerebral Palsy
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 3 Months to 5 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Parkinson's Disease
Interventions: Rasagiline, Placebo; Drug
Lead sponsor: University of Florida; Other
Eligibility: 40 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 3
States / cities: Aurora, Colorado • Gainesville, Florida • Cleveland, Ohio

Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis
Interventions: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine, ActHIB, PedvaxHIB, Pediarix, Prevnar, M-M-R II, Varivax; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 6 Weeks to 15 Months
Enrollment: 4,441 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 88
States / cities: Birmingham, Alabama • Phoenix, Arizona • Bryant, Arkansas + 76 more

Conditions: Spinal Cord Diseases
Interventions: Laminoplasty, laminectomy; Device · Procedure
Lead sponsor: Synthes USA HQ, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 4
States / cities: Beverly Hills, California • New Haven, Connecticut • Kansas City, Missouri + 1 more

Conditions: Ankle Sprain
Interventions: High velocity, low amplitude stretch, Slow, mobilization stretch, Passive Positioning; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 60 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anxiety Disorders and Symptoms, PTSD and Trauma-related Symptoms, Alcohol; Use, Problem; Alcohol Use Disorder
Interventions: Personalized intervention condition: Cognitive behavioral therapy skills, Therapeutic control condition: Cognitive behavioral therapy skills, Tracking control condition: Supportive counseling; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 65 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Sickle Cell Anemia
Interventions: Not listed
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years to 55 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Multiple Sclerosis, Fatigue, Insomnia
Interventions: Suvorexant, Placebo; Drug
Lead sponsor: Theodore R. Brown, MD MPH; Other
Eligibility: 18 Years to 75 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Kirkland, Washington

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Olodaterol (BI1744), placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 625 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 21
States / cities: Jasper, Alabama • Berkeley, California • Los Angeles, California + 17 more

Conditions: Nightmares
Interventions: ERRT-M for Nightmares; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 65 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Fort Hood, Texas

Search by objective public record fields.

Examining the Efficacy of the Man Therapy Platform in Reducing Problematic Anger Among Military Service Members With and Without a TBI History

Long Duration Activity and Metabolic Control After Spinal Cord Injury

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

A Patch Free Treatment for Young Children With Amblyopia

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol

INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

Assessing the Diagnostic Accuracy of an On-line Questionnaire for Diagnosis of Primary Headache Disorders

A Comparison Trial Between PCA and Epidural Analgesia for Pectus Excavatum Repair

Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury

Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression

Durham Connects RCT Evaluation II

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Treatment of Dysphagia Using the Mendelsohn Maneuver

Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers With and Without Cerebral Palsy

Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Comparison of Cervical Laminectomy to Laminoplasty

Ankle Sprains and Corticospinal Excitability

Personalizing Treatment Delivery

Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease

A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia

12 / 48 Week Pivotal PFT vs PBO in COPD I

A Trial of Treatment for Trauma-Related Nightmares in Active Duty Military Personnel